Neuland Laboratories Limited has submitted a regulatory disclosure under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, intimating about scheduled analyst and institutional investor meetings.
The Company's management will participate in the Goldman Sachs Global Healthcare CDMO Day event scheduled for September 23-25, 2026, in Singapore. The nature of the meetings includes both group meetings and one-on-one interactions with analysts and institutional investors.
The disclosure explicitly notes that the schedule and participant list for these meetings are subject to change due to any exigencies on the part of either the participants or the Company.
The intimation was digitally signed by Sarada Bhamidipati, Company Secretary of Neuland Laboratories Limited, on September 16, 2026, at 16:00:54 IST, and addressed to both BSE Limited and the National Stock Exchange of India Limited.